Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1386301/000155837022008784/rsss-20220331x10q.htm
December 2023
December 2023
November 2023
November 2023
November 2023
September 2023
September 2023
August 2023
August 2023
August 2023
Exhibit 99.1
FOR IMMEDIATE RELEASE
Research Solutions Reports Fiscal Third Quarter 2022 Results
Reports Record Quarterly Revenue and 32 Percent Increase in ARR to $7.3 Million
HENDERSON, Nev., May 12, 2022 — Research Solutions, Inc. (NASDAQ: RSSS), a pioneer in providing cloud-based workflow solutions for R&D driven organizations, reported financial results for its fiscal third quarter ended March 31, 2022.
Fiscal Third Quarter 2022 Summary
· | Total revenue of $8.8 million, a quarterly record for the Company and a 5% increase from the prior-year quarter | |
· | Platform revenue up 33% to $1.8 million. Annual Recurring Revenue (“ARR”) up 32% to $7.3 million | |
· | Gross profit up 20% from prior-year quarter. Total gross margin improved 460 basis points to 37.0% | |
· | Loss of $0.01 per share, compared to breakeven in the prior-year quarter, positive Adjusted EBITDA of $0.1 million compared to $0.2M in the prior-year quarter | |
· | Platform incremental ARR generated in the quarter was $0.5M and a total of $1.8M in the past twelve months. | |
· | 34 net new platform deployments in the quarter, 168 net new on a trailing twelve months basis |
“Our third quarter results reflect the continued growth within our Platforms segment, as we posted our highest quarterly total revenue in company history and second consecutive quarter of at least $500,000 of incremental ARR,” said Roy W. Olivier, President and CEO of Research Solutions. “In addition, Q3 is seasonally a strong renewal period for us and this quarter we experienced our highest ever upsell bookings from existing customers as they continue to see the value in our Article Galaxy platform.”
Fiscal Third Quarter 2022 Results
Total revenue was $8.8 million, a 5% increase from $8.3 million in the year-ago quarter as platform revenue increased and transaction revenue was essentially unchanged from the prior period.
Platform subscription revenue increased 33% to $1.8 million compared to approximately $1.3 million in the year-ago quarter. The growth was due to an increase in ARR associated with renewals over the last twelve months as well as an increase in the total number of paid Platform deployments, including 34 net deployments added in the quarter. The quarter ended with annual recurring revenue of $7.3 million, up 32% year-over-year (see the company’s definition of annual recurring revenue below).
Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1386301/000155837022008784/rsss-20220331x10q.htm
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Research Solutions, Inc..
Research Solutions, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:
Rating
Learn More![]()
Adjusted EBITDA has limitations as an analytical tool, which includes, among others, the following: Adjusted EBITDA does not reflect our cash expenditures, or future requirements, for capital expenditures or contractual commitments; Adjusted EBITDA does not reflect changes in, or cash requirements for, our working capital needs; Adjusted EBITDA does not reflect interest expense, or the cash requirements necessary to service interest or principal payments, on our debts; and Although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and Adjusted EBITDA does not reflect any cash requirements for such replacements.
General and administrative 395,768 Increased due to greater personnel costs and accounting, consulting and legal expenses.
General and administrative 1,229,314 Increased due to greater personnel costs and accounting, consulting and legal expenses.
Actual results and the timing of events could differ materially from those anticipated in these forward-looking statements as a result of a number of factors, including those set forth under "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended June 30, 2021.
29 Set forth below is a reconciliation of Adjusted EBITDA to net income (loss) for the three and nine months ended March 31, 2022 and 2021: We present Adjusted EBITDA because we believe it assists investors and analysts in comparing our performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance.
Transactions 0.6 Decreased primarily due...Read more
We apply the following five...Read more
Technology and product development 307,764...Read more
Technology and product development 749,752...Read more
Gross Profit The difference between...Read more
In addition, we use Adjusted...Read more
To date, we have not...Read more
Furthermore, capital markets and economies...Read more
20 Revenues are recognized when...Read more
We leverage our Platform's efficiencies...Read more
Net loss increased $997,904 or...Read more
The severity of the impact...Read more
In evaluating Adjusted EBITDA, you...Read more
Greater personnel costs include separation...Read more
However, Adjusted EBITDA is not...Read more
Platforms 5.1 Decreased primarily due...Read more
Platforms 3.5 Decreased primarily due...Read more
In addition to our GAAP...Read more
Operating Activities Net cash used...Read more
Transactions 25,221 Decreased primarily due...Read more
Transactions 361,070 Decreased primarily due...Read more
28 Net cash provided by...Read more
Our presentation of Adjusted EBITDA...Read more
Transactions 1.2 Decreased primarily due...Read more
There were no outstanding borrowings...Read more
Stock-Based Compensation The fair value...Read more
We define Adjusted EBITDA as...Read more
The following table sets forth...Read more
Total revenue increased $833,451, or...Read more
Cost of Revenue The difference...Read more
We derive our revenues from...Read more
Financial Statements, Disclosures and Schedules
Inside this 10-Q Quarterly Report
Material Contracts, Statements, Certifications & more
Research Solutions, Inc. provided additional information to their SEC Filing as exhibits
Ticker: RSSS
CIK: 1386301
Form Type: 10-Q Quarterly Report
Accession Number: 0001558370-22-008784
Submitted to the SEC: Fri May 13 2022 5:06:43 PM EST
Accepted by the SEC: Fri May 13 2022
Period: Thursday, March 31, 2022
Industry: Business Services